ALZN

Alzamend Neuro Inc

1.200

+0.040+3.45%

After Hours: 1.320 +0.120 +10.00%17:59 06/30 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.135/1.160

TODAY RANGE1.120-1.250

VOL1.83M

MARKET CAP4.57M

52 WEEK RANGE0.8400-3.600

AVG VOL (3M)102.86K

% TURNOVER48.08%

TURNOVER--

P/E (TTM)-0.2615

% RANGE11.21%

EPS(TTM)-4.5891

P/E(FORWARD)-0.4651

P/B2.090

BVPS0.5742

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP4.54M

SHARES OUTSTANDING3.80M

NEXT EARNINGS07/20-07/25

FREE FLOAT3.78M

LOT SIZE1

EX-DATE05/12/2025

Feeds

News

Press Releases

Financial Reports

Profile

Same Industry

Name/Symbol

Change%

Price

ALZN

Regeneron Pharmaceuticals

REGN

+2.06%

632.90

GridAI Tech

GRDX

+1.85%

4.410

BIONTECH

BNTX

+1.36%

91.22

United Therapeutics Corp.

UTHR

-0.13%

542.66

Vertex Pharmaceuticals Inc

VRTX

+2.32%

491.34

Siga Technologie

SIGA

-0.76%

3.920

Moderna

MRNA

+12.59%

67.27

Charles Riv Labs Intl Inc

CRL

+1.43%

215.75

Medpace Holdings

MEDP

+1.37%

527.07

Talphera Inc

TLPH

-3.74%

1.030

ICON plc

ICLR

+5.53%

169.86

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

+2.53%

191.14

MOLECULAR PARTNERS AG

MOLN

-3.31%

3.800

PRA Health

PRAH

0.00%

165.21

Arcturus Therape

ARCT

+0.88%

6.88

Gilead Sciences Inc

GILD

+3.26%

127.88

Incyte Corp

INCY

+5.78%

113.75

Aptevo Therapeutics Inc

APVO

-0.66%

4.550

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.